Significantly higher numbers of CD11c+ myeloid DC (mDC) were found in tumor tissues compared to healthy controls, with a proportion of mDC presenting an immature phenotype, potentially associated with cancer progression. The gene discussed is ITGAX; the disease is neoplasm.